These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 22017508)
21. Molecular dynamics simulations of CYP2E1. Li J; Wei DQ; Wang JF; Yu ZT; Chou KC Med Chem; 2012 Mar; 8(2):208-21. PubMed ID: 22385180 [TBL] [Abstract][Full Text] [Related]
22. Type II ligands as chemical auxiliaries to favor enzymatic transformations by P450 2E1. Ménard A; Fabra C; Huang Y; Auclair K Chembiochem; 2012 Nov; 13(17):2527-36. PubMed ID: 23129539 [TBL] [Abstract][Full Text] [Related]
23. Active site topology of human cytochrome P450 2E1. Mackman R; Guo Z; Guengerich FP; Ortiz de Montellano PR Chem Res Toxicol; 1996; 9(1):223-6. PubMed ID: 8924594 [TBL] [Abstract][Full Text] [Related]
24. Pulmonary bioactivation of trichloroethylene to chloral hydrate: relative contributions of CYP2E1, CYP2F, and CYP2B1. Forkert PG; Baldwin RM; Millen B; Lash LH; Putt DA; Shultz MA; Collins KS Drug Metab Dispos; 2005 Oct; 33(10):1429-37. PubMed ID: 15987776 [TBL] [Abstract][Full Text] [Related]
25. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1. Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706 [TBL] [Abstract][Full Text] [Related]
27. Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates. Porubsky PR; Meneely KM; Scott EE J Biol Chem; 2008 Nov; 283(48):33698-707. PubMed ID: 18818195 [TBL] [Abstract][Full Text] [Related]
28. Baculovirus expression and purification of human and rat cytochrome P450 2E1. Chen W; Peter RM; McArdle S; Thummel KE; Sigle RO; Nelson SD Arch Biochem Biophys; 1996 Nov; 335(1):123-30. PubMed ID: 8914842 [TBL] [Abstract][Full Text] [Related]
29. Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase). Jones BC; Hawksworth G; Horne VA; Newlands A; Morsman J; Tute MS; Smith DA Drug Metab Dispos; 1996 Feb; 24(2):260-6. PubMed ID: 8742240 [TBL] [Abstract][Full Text] [Related]
30. Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective. Miller GP Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1053-64. PubMed ID: 18680440 [TBL] [Abstract][Full Text] [Related]
31. Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Carpenter SP; Lasker JM; Raucy JL Mol Pharmacol; 1996 Feb; 49(2):260-8. PubMed ID: 8632758 [TBL] [Abstract][Full Text] [Related]
32. Cloning of canine cytochrome P450 2E1 cDNA: identification and characterization of two variant alleles. Lankford SM; Bai SA; Goldstein JA Drug Metab Dispos; 2000 Aug; 28(8):981-6. PubMed ID: 10901710 [TBL] [Abstract][Full Text] [Related]
33. Differential modulation of CYP2E1 activity by cAMP-dependent protein kinase upon Ser129 replacement. Oesch-Bartlomowicz B; Padma PR; Becker R; Richter B; Hengstler JG; Freeman JE; Wolf CR; Oesch F Exp Cell Res; 1998 Jul; 242(1):294-302. PubMed ID: 9665827 [TBL] [Abstract][Full Text] [Related]
35. [A turning point in the knowledge of the structure-function-activity relations of elastin]. Alix AJ J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705 [TBL] [Abstract][Full Text] [Related]
36. [The modeling of interactions of the CYP2E1 isoform of human cytochrome P450 with substrates]. Potemkin VA; Grishina MA; Bartashevich EV; Zrakova TIu; Pogrebnoĭ AA Biofizika; 2005; 50(3):418-22. PubMed ID: 15977830 [TBL] [Abstract][Full Text] [Related]
37. CYP2E1 substrate inhibition. Mechanistic interpretation through an effector site for monocyclic compounds. Collom SL; Laddusaw RM; Burch AM; Kuzmic P; Perry MD; Miller GP J Biol Chem; 2008 Feb; 283(6):3487-3496. PubMed ID: 18056994 [TBL] [Abstract][Full Text] [Related]
38. Acetaldehyde as well as ethanol is metabolized by human CYP2E1. Kunitoh S; Imaoka S; Hiroi T; Yabusaki Y; Monna T; Funae Y J Pharmacol Exp Ther; 1997 Feb; 280(2):527-32. PubMed ID: 9023260 [TBL] [Abstract][Full Text] [Related]
39. Minipig cytochrome P450 2E1: comparison with human enzyme. Baranová J; Anzenbacherová E; Anzenbacher P; Soucek P Drug Metab Dispos; 2005 Jun; 33(6):862-5. PubMed ID: 15778271 [TBL] [Abstract][Full Text] [Related]
40. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. Ding J; Das K; Hsiou Y; Sarafianos SG; Clark AD; Jacobo-Molina A; Tantillo C; Hughes SH; Arnold E J Mol Biol; 1998 Dec; 284(4):1095-111. PubMed ID: 9837729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]